Allosteric modulators of ligand binding to muscarinic acetylcholine receptors

[1]  Action of atropine and some hexane-1.6-bis-ammonium derivatives upon the toxicity of DFP im mice. , 1968, European journal of pharmacology.

[2]  [Effects and mechanisms of action of alkan-bis-ammonium derivatives in organophosphate poisoning]. , 1969 .

[3]  O. Wassermann,et al.  Inhibition of the actions of carbachol and DFP on guinea pig isolated atria by alkane-bis-ammonium compounds. , 1969, European journal of pharmacology.

[4]  L. Kier,et al.  Nature of Anionic or α‐Site of Cholinesterase , 1975 .

[5]  F. Mitchelson,et al.  THE INHIBITORY EFFECT OF GALLAMINE ON MUSCARINIC RECEPTORS , 1976, British journal of pharmacology.

[6]  N. Birdsall,et al.  Modification of the binding properties of muscarinic receptors by gallamine. , 1983, Molecular pharmacology.

[7]  P. de Neef,et al.  Inhibitory effects of quinidine on rat heart muscarinic receptors. , 1984, Life sciences.

[8]  J. Nunnari,et al.  Regulation of porcine brain alpha 2-adrenergic receptors by Na+,H+ and inhibitors of Na+/H+ exchange. , 1987, The Journal of biological chemistry.

[9]  B. Rauch,et al.  Verapamil interaction with the muscarinic receptor: stereoselectivity at two sites. , 1987, Biochemical pharmacology.

[10]  K. Mohr,et al.  Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication. , 1988, Pharmacology & toxicology.

[11]  F. Ehlert,et al.  Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. , 1988, Molecular pharmacology.

[12]  Gallamine exerts biphasic allosteric effects at muscarinic receptors. , 1989, Molecular pharmacology.

[13]  J. Fergus,et al.  Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes. , 1990, Molecular pharmacology.

[14]  K. Mohr,et al.  Interaction of the hexamethonium derivative W84, an allosteric effector at muscarinic cholinoreceptors, with rat brain nicotinic binding sites. , 1990, Pharmacology & toxicology.

[15]  J. Vorlíček,et al.  Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors. , 1990, Molecular pharmacology.

[16]  M. Brann,et al.  Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes. , 1991, Biochemical pharmacology.

[17]  E. El-Fakahany,et al.  Allosteric antagonists of the muscarinic acetylcholine receptor. , 1991, Biochemical pharmacology.

[18]  J. Ellis,et al.  Two allosteric modulators interact at a common site on cardiac muscarinic receptors. , 1992, Molecular pharmacology.

[19]  F. Ehlert,et al.  Heparin, dextran and trypan blue allosterically modulate M2 muscarinic receptor binding properties and interfere with receptor-mediated inhibition of adenylate cyclase. , 1992, The Journal of pharmacology and experimental therapeutics.

[20]  K. Jakobs,et al.  Agonist-independent inhibition of G protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes. , 1992, European journal of pharmacology.

[21]  Equipotent allosteric effect of W84 on [3H]NMS-binding to cardiac muscarinic receptors from guinea-pig, rat, and pig. , 1992, Pharmacology & toxicology.

[22]  M. Brann,et al.  Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. , 1993, Molecular pharmacology.

[23]  J. Gasteiger,et al.  FROM ATOMS AND BONDS TO THREE-DIMENSIONAL ATOMIC COORDINATES : AUTOMATIC MODEL BUILDERS , 1993 .

[24]  J. Proska,et al.  Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors. , 1994, Molecular pharmacology.

[25]  M. Eck,et al.  Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor. , 1994, Molecular pharmacology.

[26]  Evi Kostenis,et al.  P79 dependence of the potency of bisquaternary allosteric modulators of M2-cholinoceptors on the length of the central alkyl chain , 1994 .

[27]  J. Gasteiger,et al.  The beauty of molecular surfaces as revealed by self-organizing neural networks. , 1994, Journal of molecular graphics.

[28]  Evi Kostenis,et al.  Allosteric effect on muscarinic M2-receptors of derivatives of the alkane-bis-ammonium compound W84: comparison with bispyridinium-type allosteric modulators , 1994 .

[29]  U Holzgrabe,et al.  Search for the pharmacophore of bispyridinium-type allosteric modulators of muscarinic receptors. , 1994, Journal of medicinal chemistry.

[30]  Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors. , 1994, Molecular pharmacology.

[31]  U Holzgrabe,et al.  A Stable and Highly Potent Hexamethonium Derivative Which Modulates Muscarinic Receptors Allosterically in Guinea‐pig Hearts , 1994, The Journal of pharmacy and pharmacology.

[32]  Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors. , 1994, Molecular pharmacology.

[33]  J. Jakubík,et al.  Positive allosteric interactions on cardiac muscarinic receptors: effects of chemical modifications of disulphide and carboxyl groups. , 1995, European journal of pharmacology.

[34]  J. Proska,et al.  Allosteric modulation of muscarinic acetylcholine receptors. , 1995, Trends in pharmacological sciences.

[35]  Potentiation by alcuronium of the antimuscarinic effect of N-methylscopolamine in guinea pig left atria. , 1995, European journal of pharmacology.

[36]  E. El-Fakahany,et al.  Positive and negative allosteric interactions on muscarinic receptors. , 1995, European journal of pharmacology.

[37]  L. Bačáková,et al.  Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors. , 1995, The Journal of pharmacology and experimental therapeutics.

[38]  S. Lazareno,et al.  Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. , 1995, Molecular pharmacology.

[39]  J. Proska,et al.  Competition between positive and negative allosteric effectors on muscarinic receptors. , 1995, Molecular pharmacology.

[40]  S. Lazareno,et al.  Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis. , 1995, Molecular pharmacology.

[41]  J. Proska,et al.  Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors. , 1996, European journal of pharmacology.

[42]  J. Gasteiger,et al.  Comparison of structurally different allosteric modulators of muscarinic receptors by self-organizing neural networks. , 1996, Journal of molecular graphics.

[43]  E. Kostenis,et al.  KOSTENIS AND MOHR REPLY : COMPOSITE ACTION OF ALLOSTERIC MODULATORS ON LIGAND BINDING , 1996 .

[44]  E. El-Fakahany,et al.  Selective enhancement of antagonist ligand binding at muscarinic M2 receptors by heparin due to receptor uncoupling. , 1996, European journal of pharmacology.

[45]  D. A. Dougherty,et al.  Cation-π Interactions in Chemistry and Biology: A New View of Benzene, Phe, Tyr, and Trp , 1996, Science.

[46]  Search for lead structures to develop new allosteric modulators of muscarinic receptors. , 1996, The Journal of pharmacology and experimental therapeutics.

[47]  E. Kostenis,et al.  Evidence for a multiple binding mode of bispyridinium-type allosteric modulators of muscarinic receptors. , 1996, European journal of pharmacology.

[48]  Anton J. Hopfinger,et al.  Conformational Analysis, Molecular Shape Comparison, and Pharmacophore Identification of Different Allosteric Modulators of Muscarinic Receptors , 1996, J. Chem. Inf. Comput. Sci..

[49]  E. Kostenis,et al.  Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation. , 1996, Trends in pharmacological sciences.

[50]  Influence of allosteric modulators of muscarinic receptors on the dissociation characteristics of radioligands of A1-adenosine-, α1 - and β-adrenergic receptors , 1997 .

[51]  F. Bymaster,et al.  In vivo pharmacology of butylthio[2.2.2] (LY297802 / NNC11-1053), an orally acting antinociceptive muscarinic agonist. , 1997, Life sciences.

[52]  J. Ellis.  Allosteric binding sites on muscarinic receptors , 1997 .

[53]  Allosteric effects of cations on muscarinic receptors , 1997 .

[54]  K. Mohr,et al.  Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors. , 1997, Molecular pharmacology.

[55]  A. Christopoulos,et al.  Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors. , 1997, The Journal of pharmacology and experimental therapeutics.

[56]  K. Mohr,et al.  Molecular rigidity and potency of bispyridinium type allosteric modulators at muscarinic M2-receptors. , 1997, Life sciences.

[57]  J. Growdon.  Muscarinic agonists in Alzheimer's disease. , 1997, Life sciences.

[58]  S. Lazareno,et al.  Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes. , 1997, Life sciences.

[59]  L. Bačáková,et al.  Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. , 1997, Molecular pharmacology.

[60]  K. Mohr,et al.  M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site. , 1998, Molecular pharmacology.